Compare DX & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DX | ITGR |
|---|---|---|
| Founded | 1987 | 1970 |
| Country | United States | United States |
| Employees | 28 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | N/A | 2000 |
| Metric | DX | ITGR |
|---|---|---|
| Price | $13.21 | $91.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $14.75 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 3.9M | 410.9K |
| Earning Date | 04-20-2026 | 04-30-2026 |
| Dividend Yield | ★ 15.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ $5.66 | $189.27 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $11.76 | $62.00 |
| 52 Week High | $14.93 | $123.78 |
| Indicator | DX | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 53.04 |
| Support Level | $13.15 | $82.58 |
| Resistance Level | $14.09 | $91.66 |
| Average True Range (ATR) | 0.18 | 2.25 |
| MACD | 0.04 | -0.17 |
| Stochastic Oscillator | 77.69 | 46.71 |
Dynex Capital Inc is a real estate investment trust (REIT) focused on delivering dividends supported by long term returns from investments in mortgage assets backed by U.S. housing and commercial real estate. The Company is internally managed and mainly invests in residential and commercial mortgage-backed securities (RMBS and CMBS), which are Agency securities guaranteed by U.S. government-sponsored enterprises (GSEs). It manages interest rate, prepayment, spread, liquidity, and counterparty risks and operates through one reportable segment investing in MBS funded with repurchase agreements and equity.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.